设为首页 加入收藏

TOP

Evista(Raloxifene Tablets)
2017-03-19 11:02:19 来源: 作者: 【 】 浏览:443次 评论:0

Generic Name and Formulations:
Raloxifene HCl 60mg; tabs.
Company:
Lilly, Eli and Company

Select therapeutic use: Bone disorders
Breast cancer
Indications for EVISTA:
Prevention and treatment of osteoporosis in postmenopausal women.

Adult:
60mg once daily.

Children:
Not recommended.

Contraindications:
Active or history of venous thromboembolic events. Nursing mothers. Pregnancy (Cat.X). Women who may become pregnant.

Warnings/Precautions:
Not for use in premenopausal women. Concomitant systemic estrogen therapy: not recommended. Discontinue 72 hours before, and during prolonged immobilization; resume when fully ambulatory. Coronary heart disease or risk of coronary event (increased risk of death due to stroke). Hepatic dysfunction. Moderate to severe renal impairment.

Interactions:
May antagonize warfarin; monitor. Avoid concomitant cholestyramine, other anion exchange resins. Caution with other highly protein-bound drugs (eg, diazepam, diazoxide, lidocaine).

Pharmacological Class:
Selective estrogen receptor modulator (SERM).

Adverse Reactions:
Hot flashes, leg cramps, peripheral edema, flu syndrome, arthralgia, sweating; rare: venous thromboembolic events.

How Supplied:
Tabs—30, 100, 2000
Indications for EVISTA:
Reduction in risk of invasive breast cancer in postmenopausal women: with osteoporosis and/or at high risk for invasive breast cancer.

Adult:
60mg once daily.

Children:
Not recommended.

Contraindications:
Active or history of venous thromboembolic events. Nursing mothers. Pregnancy (Cat.X). Women who may become pregnant.

Warnings/Precautions:
Not for use in premenopausal women. Concomitant systemic estrogen therapy: not recommended. Discontinue 72 hours before, and during prolonged immobilization; resume when fully ambulatory. Coronary heart disease or risk of coronary event (increased risk of death due to stroke). Hepatic dysfunction. Moderate to severe renal impairment.

Interactions:
May antagonize warfarin; monitor. Avoid concomitant cholestyramine, other anion exchange resins. Caution with other highly protein-bound drugs (eg, diazepam, diazoxide, lidocaine).

Pharmacological Class:
Selective estrogen receptor modulator (SERM).

Adverse Reactions:
Hot flashes, leg cramps, peripheral edema, flu syndrome, arthralgia, sweating; rare: venous thromboembolic events.

How Supplied:
Tabs—30, 100, 2000 

以下是“全球医药”详细资料
Tags: 责任编辑:admin
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇KISQALI(ribociclib) tablets 下一篇Evamist(estradiol transdermal s..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位